---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-024893"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:54:29.413183+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Azenta Q3 revenue $173M (+4% YoY); non-GAAP EPS $0.16 beat; FY revenue guidance cut but EBITDA margin expansion raised

## Summary
- Q3 revenue $173M, up 4% YoY, organic growth 5%. Sample Mgmt Solutions $81M (+7%), Multiomics $64M (flat), B Medical $29M (+7%).
- GAAP diluted EPS from continuing ops -$0.12; non-GAAP diluted EPS $0.16 vs $0.13 prior year. Adjusted EBITDA $18M, margin 10.3% (+260bps YoY).
- FY2024 revenue guidance lowered to $652-658M (organic down 1-2%); adjusted EBITDA margin expansion ~300bps; non-GAAP EPS guidance raised to $0.30-$0.36.
- Repurchased 4.2M shares for $225.9M in Q3; expects to complete remaining $1.5B authorization by Oct 2024.

## SEC filing metadata
- accession: 0001437749-24-024893
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000143774924024893/0001437749-24-024893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000143774924024893/azta20240603_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-024893
- JSON: https://secwatch.observer/filing/0001437749-24-024893.json
- Plain text: https://secwatch.observer/filing/0001437749-24-024893.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.